Development Level

Tbio 6 | 10,625

Disease

Renal agenesis 4 | 25
Branchio-Oto-Renal Syndrome 3 | 4
Branchiootic syndrome 3 | 10
Branchiootorenal syndrome 3 | 9
Cancer 3 | 2,346
glioblastoma 3 | 5,572
medulloblastoma, large-cell 3 | 6,234
Branchiooculofacial syndrome 2 | 13
Congenital Abnormality 2 | 11
Craniofacial Abnormalities 2 | 147
Kidney disease 2 | 396
Lacrimal duct obstruction 2 | 5
Townes-Brocks syndrome 2 | 15
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
sonic hedgehog group medulloblastoma 2 | 1,482
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Alzheimer's disease 1 | 644
Amphetamine-Related Disorders 1 | 74
Amyotrophic Lateral Sclerosis 1 | 431
Aniridia 1 | 26
BRANCHIOOTIC SYNDROME 3 (disorder) 1 | 1
Bilateral renal hypoplasia 1 | 1
Brain disease 1 | 83
Branchiootorenal Syndrome 2 1 | 1
Breast cancer 1 | 3,094
CCHS WITH HIRSCHSPRUNG DISEASE 1 | 5
Cerebrovascular disease 1 | 231
Cervix endometriosis 1 | 3
Cleft Lip 1 | 91
Cleft palate 1 | 125
Cocaine-Related Disorders 1 | 88
Coloboma 1 | 51
Congenital Heart Defects 1 | 37
Congenital central hypoventilation 1 | 6
DEAFNESS, AUTOSOMAL DOMINANT 23 1 | 1
Denys-Drash syndrome 1 | 11
Duodenogastric reflux 1 | 8
Dyskinesia, Drug-Induced 1 | 15
Endometriosis 1 | 535
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 1 | 1
Fara Chlupackova syndrome 1 | 2
Female Urogenital Diseases 1 | 18
Frontonasal dysplasia 1 | 4
Glaucoma 1 | 134
Glioma 1 | 65
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3 1 | 1
Hirschsprung Disease 1 | 11
Hirschsprung disease type 3 1 | 1
Hirschsprung's disease 1 | 42
Huntington Disease 1 | 12
Huntington's disease 1 | 72
Hyperalgesia 1 | 71
Kidney Diseases 1 | 86
Kidney Failure, Chronic 1 | 45
Metanephric adenoma 1 | 9
Microphthalmia 1 | 78
Multiple endocrine neoplasia type 2A 1 | 22
Multiple endocrine neoplasia type 2B 1 | 16
Myocardial stunning 1 | 8
Myotonic dystrophy type 1 1 | 16
Nephroblastoma 1 | 45
Nephrogenic adenoma 1 | 10
Nephrogenic adenoma of urinary bladder 1 | 2
Neurodegenerative Disorders 1 | 37
Neurologic Manifestations 1 | 4
Neuropathy 1 | 210
Nonsyndromic deafness 1 | 121
Oxyphilic adenoma 1 | 21
Papillorenal syndrome 1 | 1
Parkinson Disease 1 | 102
Parkinson's disease 1 | 364
Parkinsonian Disorders 1 | 23
Pheochromocytoma 1 | 22
Retinal Degeneration 1 | 49
Secondary Parkinson Disease 1 | 8
Sensorineural hearing loss 1 | 107
Status Epilepticus 1 | 85
Toxic encephalopathy 1 | 131
Vesicoureteral reflux 1 | 28
astrocytic glioma 1 | 2,241
breast carcinoma 1 | 1,614
cystic fibrosis 1 | 1,665
ependymoma 1 | 2,514
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
nasopharyngeal carcinoma 1 | 1,056
non-inflammatory breast cancer 1 | 208
osteosarcoma 1 | 7,933
ovarian cancer 1 | 8,484
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Transcription Factor 4 | 1,400
Non-IDG 2 | 11,971

Grant Application

5R01DK064640-08 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Glial cell line-derived neurotrophic factor GDNF Tbio Non-IDG -3.30206 2301.5 303
Paired box protein Pax-2 PAX2 Tbio Transcription Factor -2.65970 471.8 306
Homeobox protein SIX2 SIX2 Tbio Transcription Factor -1.75384 56.3 116
Homeobox protein SIX1 SIX1 Tbio Transcription Factor -2.59361 406.9 91
Homeobox protein SIX5 SIX5 Tbio Transcription Factor -2.46537 283.6 102
Eyes absent homolog 1 EYA1 Tbio Non-IDG -2.01339 108.4 107